华纳药厂
(688799)
| 流通市值：66.55亿 | | | 总市值：66.55亿 |
| 流通股本：1.34亿 | | | 总股本：1.34亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 660,691,577.24 | 324,546,325.12 | 1,504,231,254.46 | 1,085,824,496.38 |
| 营业收入 | 660,691,577.24 | 324,546,325.12 | 1,504,231,254.46 | 1,085,824,496.38 |
| 二、营业总成本 | 593,388,043.18 | 292,515,876.27 | 1,359,745,544.14 | 966,629,718.63 |
| 营业成本 | 287,271,277.15 | 138,639,611.3 | 597,399,813.55 | 425,692,684.24 |
| 税金及附加 | 6,876,153.82 | 4,274,644.44 | 14,942,179.13 | 11,739,218.38 |
| 销售费用 | 195,065,356.75 | 104,071,599.16 | 496,587,367.7 | 369,755,662.02 |
| 管理费用 | 47,324,843.81 | 24,367,112.26 | 121,176,173.57 | 71,155,165.37 |
| 研发费用 | 53,761,057.2 | 21,012,971.29 | 129,850,572.86 | 96,053,853.24 |
| 财务费用 | 3,089,354.45 | 149,937.82 | -210,562.67 | -7,766,864.62 |
| 其中:利息费用 | 2,526,792.78 | 1,166,256.14 | 647,365.69 | - |
| 其中:利息收入 | 877,238.33 | 1,683,430 | 1,951,156.52 | 8,414,515.27 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | 3,203,427.26 | -573,067.35 | 84,335,073.56 | 87,359,777.29 |
| 资产处置收益 | - | - | -413.06 | - |
| 资产减值损失(新) | -1,065,215.97 | -3,990,614.81 | -8,833,358.42 | -3,913,334.52 |
| 信用减值损失(新) | -6,678,085.75 | 2,149,294.73 | -867,354.51 | -912,950.1 |
| 其他收益 | 12,017,901 | 3,573,717.59 | 21,365,284.33 | 14,795,136.92 |
| 四、营业利润 | 74,781,560.6 | 33,189,779.01 | 240,484,942.22 | 216,523,407.34 |
| 加:营业外收入 | 447.43 | 200.04 | 1,139,087.11 | 45,448.06 |
| 减:营业外支出 | 202,074.26 | 1,329.79 | 728,948.33 | 738,722.66 |
| 五、利润总额 | 74,579,933.77 | 33,188,649.26 | 240,895,081 | 215,830,132.74 |
| 减:所得税费用 | 9,980,103.77 | 6,311,669.58 | 12,796,752.4 | 18,887,579.45 |
| 六、净利润 | 64,599,830 | 26,876,979.68 | 228,098,328.6 | 196,942,553.29 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 64,599,830 | 26,876,979.68 | 228,098,328.6 | 196,942,553.29 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 64,599,830 | 26,876,979.68 | 238,279,325.55 | 207,123,550.24 |
| 少数股东损益 | - | - | -10,180,996.95 | -10,180,996.95 |
| 扣除非经常损益后的净利润 | 58,720,946.16 | 26,466,281.95 | 133,979,700.7 | 98,841,651.65 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.49 | 0.2 | 1.81 | 1.58 |
| (二)稀释每股收益 | 0.49 | 0.2 | 1.77 | 1.58 |
| 九、综合收益总额 | 64,599,830 | 26,876,979.68 | 228,098,328.6 | 196,942,553.29 |
| 归属于母公司股东的综合收益总额 | 64,599,830 | 26,876,979.68 | 238,279,325.55 | 207,123,550.24 |
| 归属于少数股东的综合收益总额 | - | - | -10,180,996.95 | -10,180,996.95 |
| 公告日期 | 2026-08-25 | 2026-04-21 | 2026-04-21 | 2025-10-31 |
| 审计意见(境内) | | | 标准无保留意见 | |